Cell and Screening Core
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 1P01AI198498-01
Grant search
Key facts
Disease
Unspecified, UnspecifiedStart & end year
20262031Known Financial Commitments (USD)
$499,070Funder
National Institutes of Health (NIH)Principal Investigator
PROFESSOR Ryan LangloisResearch Location
United States of AmericaLead Research Institution
UNIVERSITY OF MINNESOTAResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Core B. Cell and Screening Core Summary The focus of the Cell and Screening Core (Core B) is to provide the Projects with cells from diverse mammal species, validated virus stocks, and high throughput screening of virus infections across the "fibroblast zoo" with and without immune perturbation and plasmid and siRNA tools to evaluate virus-host interactions. Viruses need to use host factors to enter cells and complete their replication cycle and need to evaluate antiviral sensing, signaling, and effector protein responses. Given the complexity of these interactions and the potential involvement of many genes and gene networks live cells are needed to fully define mechanisms of species susceptibility and resistance. Fibroblasts are a relevant cell type to achieve these goals because they are target of early infection with alpha and flavivirus and are involved in sensing infection and serve as a source of virus amplification and the site of infection. Fibroblasts are also an ideal cell type for mechanistic studies because they are easy to grow up in large numbers and manipulate in culture and can also be differentiated into other tissue and cell types. This core includes a research team with diverse expertise in virology (Langlois and Cherry), high throughput screening (Cherry), work with primary cells from diverse species (Langlois, Korody, and Maidelaire), and generating stem cells from non-model animals (Korody). Aim 1 will generate primary dermal fibroblasts from diverse mammals for use in the projects and cores. It will also perform validation studies and measuring sources of biological variation. This core will also dedifferentiate fibroblasts from select species into inducible pluripotent stem cells to then differentiate into other cell types for confirmatory studies within the projects. Aim 2 will generate and validate virus stocks for use in the projects and cores. Finally, Aim 3 will perform high throughput screening of alpha and flavivirus infection across the fibroblasts zoo with and without innate immune perturbation or interferon stimulation. Together Core B will provide cells and viruses for the Projects 1 and 2 for mechanistic studies and will provide screening data for Core C and both Projects to further inform mechanisms and to aid in prioritization of virus-host species to evaluate.